{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:07:52Z","timestamp":1775257672956,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:00:00Z","timestamp":1379980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s12032-013-0711-8","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T12:17:14Z","timestamp":1379938634000},"source":"Crossref","is-referenced-by-count":8,"title":["Histo-biological comparative analysis of bilateral breast cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Bilal","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basem","family":"Morcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiez","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Sughayyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habeeb","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Almasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,24]]},"reference":[{"key":"711_CR1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1993.11.8.1545","volume":"11","author":"EA Healey","year":"1993","unstructured":"Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545\u201352.","journal-title":"J Clin Oncol."},{"issue":"11","key":"711_CR2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3816\/CBC.2007.n.052","volume":"7","author":"G Beinart","year":"2007","unstructured":"Beinart G, Gonzalez-Angulo AM, Broglio K, et al. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. Clin Breast Cancer. 2007;7(11):867\u201374.","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"711_CR3","first-page":"612","volume":"26","author":"GA Khairy","year":"2005","unstructured":"Khairy GA, Guraya SY, Ahmed ME, Ahmed MA. Bilateral breast cancer. Incidence, diagnosis and histological patterns. Saudi Med J. 2005;26(4):612\u20135.","journal-title":"Saudi Med J."},{"issue":"5","key":"711_CR4","first-page":"797","volume":"70","author":"BF Hankey","year":"1983","unstructured":"Hankey BF, Curtis RE, Naughton MD, et al. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst. 1983;70(5):797\u2013804.","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"711_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/BF00052945","volume":"7","author":"LS Cook","year":"1996","unstructured":"Cook LS, White E, Schwartz SM, et al. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control. 1996;7(3):382\u201390.","journal-title":"Cancer Causes Control"},{"issue":"2","key":"711_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/oxfordjournals.aje.a114971","volume":"128","author":"PL Horn","year":"1988","unstructured":"Horn PL, Thompson WD. Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol. 1988;128(2):309\u201323.","journal-title":"Am J Epidemiol."},{"issue":"9","key":"711_CR7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bjs.1800700902","volume":"70","author":"JM Dixon","year":"1983","unstructured":"Dixon JM, Anderson TJ, Page DL, et al. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg. 1983;70(9):513\u20136.","journal-title":"Br J Surg."},{"key":"711_CR8","first-page":"99","volume":"68","author":"EB Harvey","year":"1985","unstructured":"Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985;68:99\u2013112.","journal-title":"Natl Cancer Inst Monogr."},{"issue":"15","key":"711_CR9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"The Breast Cancer Linkage Consortium","year":"1999","unstructured":"The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91(15):1310\u20136.","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"711_CR10","first-page":"265","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995;56(1):265\u201371.","journal-title":"Am J Hum Genet."},{"issue":"8","key":"711_CR11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1993.11.8.1545","volume":"11","author":"EA Healey","year":"1993","unstructured":"Healey EA, Cook EF, Orav EJ, et al. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11(8):1545\u201352.","journal-title":"J Clin Oncol."},{"issue":"6","key":"711_CR12","first-page":"353","volume":"41","author":"K Engin","year":"1994","unstructured":"Engin K. Prognostic factors in bilateral breast cancer. Neoplasma. 1994;41(6):353\u20137.","journal-title":"Neoplasma"},{"issue":"3","key":"711_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-006-9337-2","volume":"102","author":"Y Shen","year":"2007","unstructured":"Shen Y, Dong W, Esteva FJ, et al. Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center? Breast Cancer Res Treat. 2007;102(3):347\u201356.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"711_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10549-007-9709-2","volume":"110","author":"M Schaapveld","year":"2008","unstructured":"Schaapveld M, Visser O, Louwman WJ, et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat. 2008;110(1):189\u201397.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"711_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-006-9455-x","volume":"105","author":"HM Verkooijen","year":"2007","unstructured":"Verkooijen HM, Chatelain V, Fioretta G, et al. Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat. 2007;105(3):347\u201357.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"711_CR16","first-page":"259","volume":"19","author":"MD Graham","year":"1993","unstructured":"Graham MD, Yelland A, Peacock J, et al. Bilateral carcinoma of the breast. Eur J Surg Oncol. 1993;19(3):259\u201364.","journal-title":"Eur J Surg Oncol."},{"issue":"11","key":"711_CR17","first-page":"733","volume":"59","author":"J Gogas","year":"1993","unstructured":"Gogas J, Markopoulos C, Skandalakis P, Gogas H. Bilateral breast cancer. Am Surg. 1993;59(11):733\u20135.","journal-title":"Am Surg."},{"issue":"12","key":"711_CR18","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1002\/1097-0142(20000615)88:12<2739::AID-CNCR12>3.0.CO;2-J","volume":"88","author":"DE Heron","year":"2000","unstructured":"Heron DE, Komarnicky LT, Hyslop T, et al. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 2000;88(12):2739\u201350.","journal-title":"Cancer"},{"issue":"6","key":"711_CR19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/ejso.1999.0711","volume":"25","author":"J Kollias","year":"1999","unstructured":"Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999;25(6):584\u20139.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"711_CR20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/bjs.1800710924","volume":"71","author":"MA Chaudary","year":"1984","unstructured":"Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg. 1984;71(9):711\u20134.","journal-title":"Br J Surg."},{"issue":"2","key":"711_CR21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1309\/6YEPMCHACPG2BD15","volume":"120","author":"GM Tse","year":"2003","unstructured":"Tse GM, Kung FY, Chan AB, et al. Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Am J Clin Pathol. 2003;120(2):168\u201374.","journal-title":"Am J Clin Pathol."},{"issue":"2","key":"711_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.22265","volume":"120","author":"EN Suspitsin","year":"2007","unstructured":"Suspitsin EN, Sokolenko AP, Togo AV, et al. Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: possible role of host factors and survival bias. Int J Cancer. 2007;120(2):297\u2013302.","journal-title":"Int J Cancer"},{"issue":"5","key":"711_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ijc.10530","volume":"100","author":"EN Imyanitov","year":"2002","unstructured":"Imyanitov EN, Suspitsin EN, Grigoriev MY, et al. Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas. Int J Cancer. 2002;100(5):557\u201364.","journal-title":"Int J Cancer"},{"issue":"1","key":"711_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-007-0123-1","volume":"7","author":"SC Park","year":"2007","unstructured":"Park SC, Hwang UK, Ahn SH, et al. Genetic changes in bilateral breast cancer by comparative genomic hybridisation. Clin Exp Med. 2007;7(1):1\u20135.","journal-title":"Clin Exp Med."},{"issue":"4","key":"711_CR25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/ejso.2002.1266","volume":"28","author":"AR Carmichael","year":"2002","unstructured":"Carmichael AR, Bendall S, Lockerbie L, et al. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. Eur J Surg Oncol. 2002;28(4):388\u201391.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"711_CR26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/cncr.20452","volume":"101","author":"M Intra","year":"2004","unstructured":"Intra M, Rotmensz N, Viale G, et al. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. Cancer. 2004;101(5):905\u201312.","journal-title":"Cancer"},{"issue":"3","key":"711_CR27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","volume":"102","author":"BA Virnig","year":"2010","unstructured":"Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170\u20138.","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"711_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejrad.2004.11.019","volume":"54","author":"B Barreau","year":"2005","unstructured":"Barreau B, de Mascarel I, Feuga C, et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol. 2005;54(1):55\u201361.","journal-title":"Eur J Radiol."},{"issue":"9","key":"711_CR29","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/BF03215857","volume":"25","author":"J Kollias","year":"2001","unstructured":"Kollias J, Ellis IO, Elston CW, Blamey RW. Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg. 2001;25(9):1117\u201324.","journal-title":"World J Surg."},{"issue":"6","key":"711_CR30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0959-8049(97)10121-6","volume":"34","author":"D Coradini","year":"1998","unstructured":"Coradini D, Oriana S, Mariani L, et al. Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour? Eur J Cancer. 1998;34(6):825\u201330.","journal-title":"Eur J Cancer"},{"issue":"7","key":"711_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jjco\/hym056","volume":"37","author":"SJ Gong","year":"2007","unstructured":"Gong SJ, Rha SY, Jeung HC, et al. Bilateral breast cancer: differential diagnosis using histological and biological parameters. Jpn J Clin Oncol. 2007;37(7):487\u201392.","journal-title":"Jpn J Clin Oncol."},{"issue":"1","key":"711_CR32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gyobfe.2007.09.021","volume":"36","author":"O Marpeau","year":"2008","unstructured":"Marpeau O, Ancel PY, Antoine M, et al. Synchronous bilateral breast cancer: risk factors, diagnosis, histology and treatment. Gynecol Obstet Fertil. 2008;36(1):35\u201344.","journal-title":"Gynecol Obstet Fertil."},{"issue":"10","key":"711_CR33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/modpathol.2008.35","volume":"21","author":"RS Saad","year":"2008","unstructured":"Saad RS, Denning KL, Finkelstein SD, et al. Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma. Mod Pathol. 2008;21(10):1200\u20137.","journal-title":"Mod Pathol."}],"updated-by":[{"DOI":"10.1007\/s12032-013-0758-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000}}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0711-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0711-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0711-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T12:25:40Z","timestamp":1563971140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0711-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,24]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0711-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12032-013-0758-6","asserted-by":"object"}]},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,24]]},"article-number":"711"}}